Skip to main content
Aurora Cannabis Inc. logo

Aurora Cannabis Inc. — Investor Relations & Filings

Ticker · ACB ISIN · CA05156X8504 TSX Manufacturing
Filings indexed 364 across all filing types
Latest filing 2023-08-28 Regulatory Filings
Country CA Canada
Listing TSX ACB

About Aurora Cannabis Inc.

https://www.auroramj.com/

Aurora Cannabis Inc. is a global leader in the production and distribution of cannabis and cannabis-derivative products. The company cultivates and sells a portfolio of products for both medicinal and recreational markets. Recognized as Canada's largest medical cannabis company and a trusted provider, Aurora focuses on innovative, science-based medical cannabis offerings, including dried flower and various derivative formats such as oils and edibles. The company maintains operations across 12 countries, emphasizing high-quality cultivation and rigorous product development to serve patients and consumers worldwide.

Recent filings

Filing Released Lang Actions
Report of exempt distribution (45-106F1).pdf
Regulatory Filings
2023-08-28 English
Report of voting results.pdf
Regulatory Filings
2023-08-14 English
News release - English.pdf
Regulatory Filings
2023-08-14 English
52-109F2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification by the CFO regarding the interim financial filings for the period ended June 30, 2023. It references the interim financial report and interim MD&A but does not contain the actual financial data or analysis itself. The document is a formal attestation of the accuracy and completeness of the interim filings, consistent with regulatory certification requirements (Form 52-109F2). The document length is short (3651 characters) and primarily serves as a certification rather than the interim report itself. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than as an Interim Report (IR).
2023-08-10 English
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109F2 Certification of Interim Filings by the CEO of Aurora Cannabis Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended June 30, 2023. The document is primarily an officer certification attesting to the accuracy and completeness of the interim filings and the design of internal controls. It does not contain the interim financial statements or substantive financial data itself, but rather certifies the interim filings. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report itself (IR). The document length is 3742 characters, which is relatively short and consistent with a certification letter rather than a full interim report.
2023-08-10 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management's Discussion & Analysis' for the three months ended June 30, 2023. It contains detailed financial and operational discussion, including business overview, strategy, financial review, liquidity, accounting policies, and risk factors. It references interim financial statements prepared under IAS 34 (Interim Financial Reporting) and discusses quarterly results and comparisons. The document length is about 15,000 characters, indicating a substantive report rather than a brief announcement. The content matches the definition of an Interim / Quarterly Report (IR), which includes comprehensive financial data and management analysis for a period shorter than a full fiscal year. Therefore, the correct classification is IR (Interim / Quarterly Report). Q1 2024
2023-08-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.